SEC Form 4 · accession 0001127602-18-000931
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 11:12 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2018 | S | 200 | $109.64 | D | 315,099 | D | |
| Common Stock | Jan 2, 2018 | S | 10 | $109.65 | D | 315,089 | D | |
| Common Stock | Jan 2, 2018 | S | 400 | $109.66 | D | 314,689 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.675 | D | 314,589 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.68 | D | 314,389 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.685 | D | 314,289 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.69 | D | 314,189 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.70 | D | 313,989 | D | |
| Common Stock | Jan 2, 2018 | S | 700 | $109.72 | D | 313,289 | D | |
| Common Stock | Jan 2, 2018 | S | 900 | $109.73 | D | 312,389 | D | |
| Common Stock | Jan 2, 2018 | S | 400 | $109.74 | D | 311,989 | D | |
| Common Stock | Jan 2, 2018 | S | 600 | $109.75 | D | 311,389 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $109.755 | D | 311,089 | D | |
| Common Stock | Jan 2, 2018 | S | 383 | $109.76 | D | 310,706 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.77 | D | 310,506 | D | |
| Common Stock | Jan 2, 2018 | S | 400 | $109.79 | D | 310,106 | D | |
| Common Stock | Jan 2, 2018 | S | 290 | $109.795 | D | 309,816 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.81 | D | 309,716 | D | |
| Common Stock | Jan 2, 2018 | S | 84 | $109.82 | D | 309,632 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $109.83 | D | 309,332 | D | |
| Common Stock | Jan 2, 2018 | S | 212 | $109.86 | D | 309,120 | D | |
| Common Stock | Jan 2, 2018 | S | 43 | $109.90 | D | 309,077 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $109.95 | D | 308,777 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $110.01 | D | 308,477 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $110.02 | D | 308,177 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $110.03 | D | 307,977 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.